Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience study
Journal article published in 2018 by
R. Flisiak 
,
E. Janczewska ,
M. Łucejko ,
E. Karpińska,
D. Zarębska-Michaluk ,
K. Nazzal,
B. Bolewska,
J. Białkowska,
H. Berak,
K. Fleischer-Stępniewska,
K. Tomasiewicz,
K. Karwowska,
K. Simon,
A. Piekarska,
O. Tronina
and other authors.
,
E. Janczewska ,
M. Łucejko ,
E. Karpińska,
D. Zarębska-Michaluk ,
K. Nazzal,
B. Bolewska,
J. Białkowska,
H. Berak,
K. Fleischer-Stępniewska,
K. Tomasiewicz,
K. Karwowska,
K. Simon,
A. Piekarska,
O. Tronina
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 